Nyxoah Announces First Patient Implanted in BREATHE, the U.S. Post-Approval Study of the Genio® System
Nyxoah has announced the first patient implantation in BREATHE, a U.S. post-approval study designed to evaluate the long-term safety and effectiveness of its Genio® system in treating moderate to severe obstructive sleep apnea (OSA). The multicenter study will enroll up to 229 patients across 25 U.S. centers and follow them for up to five years to …